Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT06790602. IPD Sharing: NO. Countries: 1. Publications: 1.
AS703569 and Gemcitabine Combination in Advanced Malignancies
ClinicalTrials.gov study NCT01097512. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT01884441. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT01858883. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
ClinicalTrials.gov study NCT05841420. IPD Sharing: NO. Countries: 1. Publications: 1.
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00022646. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas
ClinicalTrials.gov study NCT00001431. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT
ClinicalTrials.gov study NCT07313891. IPD Sharing: NO. Countries: 0. Publications: 2.
Scheduling Nab-paclitaxel With Gemcitabine
ClinicalTrials.gov study NCT03529175. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
ClinicalTrials.gov study NCT00059865. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00275119. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer
ClinicalTrials.gov study NCT02558868. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detect
ClinicalTrials.gov study NCT03673072. IPD Sharing: NO. Countries: 1. Publications: 1.
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
ClinicalTrials.gov study NCT01821612. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov study NCT00003216. IPD Sharing: Not stated. Countries: 2. Publications: 10.
Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT05660616. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT03943043. IPD Sharing: NO. Countries: 1. Publications: 1.
NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia
ClinicalTrials.gov study NCT00910741. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
ClinicalTrials.gov study NCT00385606. IPD Sharing: Not stated. Countries: 1. Publications: 2.
raw data of BUB1B promotes gemcitabine resistance in lung adenocarcinoma by activating the PI3K/AKT signaling pathway
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.